-
EP3941453
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3941453
| EP3941453 - THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING LYMPHOMA USING 6,8-BIS-BENZYLTHIO-OCTANOIC ACID [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 27.10.2023 Database last updated on 02.11.2024 | |
| Former | Request for examination was made Status updated on 24.12.2021 | ||
| Former | The international publication has been made Status updated on 28.09.2020 | Most recent event Tooltip | 27.10.2023 | Application deemed to be withdrawn | published on 29.11.2023 [2023/48] | Applicant(s) | For all designated states Rafael Pharmaceuticals, Inc. 1 Duncan Drive Cranbury, NJ 08512-3629 / US | For all designated states Memorial Sloan Kettering Cancer Center 1275 York Avenue New York, NY 10065 / US | For all designated states Wake Forest University Health Sciences Medical Center Boulevard Winston-Salem, NC 27157 / US | [2022/04] | Inventor(s) | 01 /
PARDEE, Timothy S. 1 Duncan Drive Cranbury, New Jersey 08512-3629 / US | 02 /
EDELSON, Jeffrey 1 Duncan Drive Cranbury, New Jersey 08512-3629 / US | 03 /
NOY, Ariela 1275 York Avenue New York, New York / US | 04 /
LAMAR, Zanetta Medical Center Boulevard Winston-Salem, North Carolina 27157 / US | [N/P] |
| Former [2022/04] | 01 /
PARDEE, Timothy S. Cranbury, New Jersey 08512-3629 / US | ||
| 02 /
EDELSON, Jeffrey Cranbury, New Jersey 08512-3629 / US | |||
| 03 /
NOY, Ariela New York, New York / US | |||
| 04 /
LAMAR, Zanetta Winston-Salem, North Carolina 27157 / US | Representative(s) | Graham Watt & Co LLP St. Botolph's House 7-9 St. Botolph's Road Sevenoaks TN13 3AJ / GB | [2022/04] | Application number, filing date | 20774107.5 | 19.03.2020 | [2022/04] | WO2020US23537 | Priority number, date | US201962820767P | 19.03.2019 Original published format: US 201962820767 P | [2022/04] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020191144 | Date: | 24.09.2020 | Language: | EN | [2020/39] | Type: | A1 Application with search report | No.: | EP3941453 | Date: | 26.01.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.09.2020 takes the place of the publication of the European patent application. | [2022/04] | Search report(s) | International search report - published on: | AU | 24.09.2020 | (Supplementary) European search report - dispatched on: | EP | 25.11.2022 | Classification | IPC: | A61K31/20, A61K31/4184, A61P35/00, A61K9/00 | [2022/52] | CPC: |
A61K9/0019 (EP,KR,US);
A61K31/20 (EP,AU,KR,US);
A61K31/4184 (EP,AU,KR,US);
A61P35/00 (EP,AU,KR,US);
A61P35/02 (KR);
A61K2300/00 (AU,KR)
| C-Set: |
A61K31/20, A61K2300/00 (AU,EP);
A61K31/4184, A61K2300/00 (AU,EP) |
| Former IPC [2022/04] | A61K31/20, A61K31/4184, A61P35/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/04] | Title | German: | THERAPEUTISCHE VERFAHREN UND ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON LYMPHOM MIT 6,8-BIS-BENZYLTHIO-OCTANSÄURE | [2022/04] | English: | THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING LYMPHOMA USING 6,8-BIS-BENZYLTHIO-OCTANOIC ACID | [2022/04] | French: | PROCÉDÉS ET COMPOSITIONS THÉRAPEUTIQUES POUR TRAITER UN LYMPHOME À L'AIDE D'ACIDE 6,8-BIS-BENZYLTHIO-OCTANOÏQUE | [2022/04] | Entry into regional phase | 15.10.2021 | National basic fee paid | 15.10.2021 | Search fee paid | 15.10.2021 | Designation fee(s) paid | 15.10.2021 | Examination fee paid | Examination procedure | 15.10.2021 | Examination requested [2022/04] | 17.05.2022 | Amendment by applicant (claims and/or description) | 24.06.2023 | Application deemed to be withdrawn, date of legal effect [2023/48] | 14.07.2023 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2023/48] | Fees paid | Renewal fee | 28.03.2022 | Renewal fee patent year 03 | 27.03.2023 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | |||